RPRX - Royalty Pharma plc

47.48
0.010   0.021%

Share volume: 3,681,476
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$47.47
0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
27%
Profitability 30%
Dept financing 16%
Liquidity 50%
Performance 22%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.75%
1 Month
8.70%
3 Months
21.28%
6 Months
28.67%
1 Year
42.50%
2 Year
58.85%
Key data
Stock price
$47.48
P/E Ratio 
28.93
DAY RANGE
$46.44 - $47.66
EPS 
$2.18
52 WEEK RANGE
$29.66 - $47.66
52 WEEK CHANGE
$40.60
MARKET CAP 
22.304 B
YIELD 
2.28%
SHARES OUTSTANDING 
576.857 M
DIVIDEND
$0.235
EX-DIVIDEND DATE
02-20-2026
NEXT EARNINGS DATE
08-07-2025
BETA 
-0.07
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,483,530
AVERAGE 30 VOLUME 
$3,840,307
Company detail
CEO: Pablo G. Legorreta
Region: US
Website: royaltypharma.com
Employees: 80
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Royalty Pharma plc was founded in 1996 and is based in New York, New York. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates.

Recent news